World’s First CRISPR-Based Gene Therapy for Blood Disorders
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) authorized the new treatment called Casgevy for patients with sickle-cell disease and transfusion-dependent beta-thalassemia aged 12...
